Annual report pursuant to Section 13 and 15(d)

Income Tax - Summary of Tax Effects of Temporary Differences and Carryforwards Rise to Deferred Tax Assets and Liabilities (Detail)

v3.24.1
Income Tax - Summary of Tax Effects of Temporary Differences and Carryforwards Rise to Deferred Tax Assets and Liabilities (Detail) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets    
Tax basis in excess of book value of assets $ 899,000 $ 899,000
Net operating loss carryforwards 48,867,000 43,380,000
Research and development deductions and credits 10,716,000 8,942,000
Stock options 1,134,000 1,042,000
Capitalized R&D expenses 11,528,000 11,342,000
Other 434,000 334,000
Total deferred tax assets 73,578,000 65,939,000
Valuation allowance (73,232,000) (65,546,000)
Net deferred tax assets 346,000 393,000
Deferred tax liabilities    
Right-of-use asset (91,000) (91,000)
Other (255,000) (302,000)
Total deferred tax liabilities (346,000) $ (393,000)
Net deferred tax assets $ 0